N-[4-[4-[2-[5-[5-[2-[4-(6-morpholin-4-yl-7H-purin-8-yl)anilino]-2-oxoethyl]-1H-pyrazol-3-yl]-2-pyridinyl]morpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-pyridin-3-yl-1H-pyrazol-5-yl)acetamide
C51H45N17O4 — CID 167040161
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[4-[2-[5-[5-[2-[4-(6-morpholin-4-yl-7H-purin-8-yl)anilino]-2-oxoethyl]-1H-pyrazol-3-yl]-2-pyridinyl]morpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-pyridin-3-yl-1H-pyrazol-5-yl)acetamide
N-[4-[4-[2-[5-[5-[2-[4-(6-morpholin-4-yl-7H-purin-8-yl)anilino]-2-oxoethyl]-1H-pyrazol-3-yl]-2-pyridinyl]morpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-pyridin-3-yl-1H-pyrazol-5-yl)acetamide (PubChem CID 167040161) has the molecular formula C51H45N17O4 and a molecular weight of 960.04 g/mol. Its IUPAC name is N-[4-[4-[2-[5-[5-[2-[4-(6-morpholin-4-yl-7H-purin-8-yl)anilino]-2-oxoethyl]-1H-pyrazol-3-yl]-2-pyridinyl]morpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-pyridin-3-yl-1H-pyrazol-5-yl)acetamide.
Molecular Properties
| Compound Name | N-[4-[4-[2-[5-[5-[2-[4-(6-morpholin-4-yl-7H-purin-8-yl)anilino]-2-oxoethyl]-1H-pyrazol-3-yl]-2-pyridinyl]morpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-pyridin-3-yl-1H-pyrazol-5-yl)acetamide |
|---|---|
| PubChem CID | 167040161 |
| Molecular Formula | C51H45N17O4 |
| Molecular Weight | 960.04 g/mol |
| Exact Mass | 959.38 |
| IUPAC Name | N-[4-[4-[2-[5-[5-[2-[4-(6-morpholin-4-yl-7H-purin-8-yl)anilino]-2-oxoethyl]-1H-pyrazol-3-yl]-2-pyridinyl]morpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-pyridin-3-yl-1H-pyrazol-5-yl)acetamide |
| SMILES | O=C(Cc1cc(-c2cccnc2)n[nH]1)Nc1ccc(-c2cc3c(N4CCOC(c5ccc(-c6cc(CC(=O)Nc7ccc(-c8nc9ncnc(N%10CCOCC%10)c9[nH]8)cc7)[nH]n6)cn5)C4)ncnc3[nH]2)cc1 |
| InChI | InChI=1S/C51H45N17O4/c69-44(22-36-20-41(65-63-36)32-2-1-13-52-25-32)58-34-8-3-30(4-9-34)40-24-38-48(60-40)54-28-56-50(38)68-16-19-72-43(27-68)39-12-7-33(26-53-39)42-21-37(64-66-42)23-45(70)59-35-10-5-31(6-11-35)47-61-46-49(62-47)55-29-57-51(46)67-14-17-71-18-15-67/h1-13,20-21,24-26,28-29,43H,14-19,22-23,27H2,(H,58,69)(H,59,70)(H,63,65)(H,64,66)(H,54,56,60)(H,55,57,61,62) |
| InChIKey | RQQKMNRURFPYSU-UHFFFAOYSA-N |
| XLogP | 6.31 |
| TPSA | 262.31 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 72 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 960.04 |
| LogP ≤ 5 | 6.31 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 15 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167040161 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.